Effectifity and Cost Analysis of Omeprazole and Pantoprazole for Stress Related Mucosal Disease Prophylaxis in ICU
Dyah Atmi Tri Sukengtyas(1*), Tri Murti Andayani(2), L. Endang Budiarti(3)
(1) Post Graduate Program, Faculty of Pharmacy, Universitas Gadjah Mada
(2) Faculty of Pharmacy, Universitas Gadjah Mada
(3) Clinical Pharmacy, Rumah Sakit Bethesda Yogyakarta
(*) Corresponding Author
Abstract
Full Text:
PDFReferences
Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care. 2005;20(1):35-45. doi:10.1016/j.jcrc.2004.10.003.
Clinical Pharmacy Working Committee. Critical-Care-Handbook-2013. 1st ed. Malaysia: Pharmaceutical Services Division Ministry of Health; 2013.
Marik PE. Handbook of Evidence-Based Critical Care. 2nd ed.; 2010.
Brett S. Science review: the use of proton pump inhibitors for gastric acid suppression in critical illness. Crit Care. 2004;9(1):45-50.
Vcev A, Stimac D, Vceva A, et al. Pantoprazole Versus Omeprazole in The Treatment of Reflux Esophagitis. Acta Medica Croat C̆asopis Hravatske Akad Med Znan. 1999;53(2):79-82.
Amaral MC, Favas C, Alves JD, Riso N, Riscado MV. Stress-related mucosal disease: Incidence of bleeding and the role of omeprazole in its prophylaxis. Eur J Intern Med. 2010;21(5):386-388. doi:10.1016/j.ejim.2010.06.010.
Zheng R-N. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. World J Gastroenterol. 2009;15(8):990. doi:10.3748/wjg.15.990.
ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis.
Mutlu GM, Mutlu EA, Factor P. GI Complications in Patients Receiving Mechanical Ventilation. Chest. 2001;119(4):1222-1241. doi:10.1378/chest.119.4.1222.
Ament PW, Dicola DB, James ME. Reducing Adverse Effects of Proton Pump Inhibitors. Am Fam Physician. 2012;86(1):66-70.
Spirt MJ. Stress-related mucosal disease: Risk factors and prophylactic therapy. Clin Ther. 2004;26(2):197-213. doi:10.1016/S0149-2918(04)90019-7.
Mohebbi L, Hesch, K. Stress Ulcer Prophylaxis in The Intensive Care Unit. Baylor Univ Med Cent Proc. 2009;22(4):373-376.
Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit care. 2001;5(6):368.
Cook D, Fuller H, Guyatt G, dkk. Risk Factors for Gastrointestinal Bleeding in Critically Ill Patient. Massachusetts Med Soc. 1994;330(6):377-381.
Mathialagan R, Hariraj R. Gastroenterology in the elderly. Medicine (Baltimore). 2015;43(6):352–355.
Yachimski PS, Friedman LS. Gastrointestinal bleeding in the elderly. Nat Clin Pract Gastroenterol Hepatol. 2008;5(2):80-93. doi:10.1038/ncpgasthep1034.
Lanas A. Nonsteroidal anti-inflammatory drugs, low-dose aspirin, and potential ways of reducing the risk of complications. Eur J Gastroenterol Hepatol. 2001;13(6):623–626.
Fagon J-Y, Chastre J, Vuagnat A, Trouillet J-L, Novara A, Gibert C. Nosocomial Pneumonia and Mortality Among Patients in Intensive Care Units. JAMA. 1996;275(11):866-869. doi:10.1001/jama.1996.03530350048033.
Udeh BL, Udeh C, Hata JS. Cost-Effectiveness of Stress Ulcer Prophylaxis: Role of Proton Pump Inhibitors. Am J Pharm Benefits. 2010;2(5):304-312.
DOI: https://doi.org/10.22146/jmpf.30119
Article Metrics
Abstract views : 6111 | views : 24280Refbacks
- There are currently no refbacks.
Copyright (c) 2017 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.